Indian equity indices ended strong on Friday, with the NIFTY closing at 23,350.40, up 159.75 points (0.69%), while the Sensex ...

Zydus Lifesciences received final USFDA approval to manufacture Apalutamide tablets for prostate cancer, following last ...

Apalutamide is an androgen receptor inhibitor indicated for the treatment of patients with metastatic castration-sensitive ...

On Monday, 1608 stocks advanced, 2503 declined and 130 remained unchanged on Bombay Stock Exchange with advance decline ratio ...

Ahmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) ...

In today's episode of Business Today TV, anchor Shailendra Bhatnagar delves into the recent fluctuations in the Indian stock markets. Despite opening 200 points down in the pre-open session, both ...

Zydus Lifesciences shares rose nearly 2% to Rs 899.40 after receiving USFDA approval to manufacture Eluxadoline Tablets (75 ...

The uptick in the Zydus Life shares came after the company received final approval from the USFDA to manufacture Eluxadoline ...

The NSE Nifty 50 ended 0.33% lower at 22,397.20, while the BSE Sensex closed 0.27% down at 73,828.9 on Thursday.

Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration to manufacture ...

Stocks including IndusInd Bank, Tata Motors, Dr Reddys, Alkem Labs, KPIT Tech, Quality Power, Brigade Enterprises and GR ...